Skip to main content

A 4852 — New Jersey

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Signed into law 222 session General Assembly

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • A 4852 is a bill in the New Jersey General Assembly, 222 session, introduced May 4, 2026.
  • Sponsored by Katz, Andrea, Sweeney, Marisa, Kearney, Vincent M., Tully, Chris, Vitale, Joseph F., Gopal, Vin, and Mukherji, Raj, with 2 cosponsors.
  • Current status: signed into law.
  • Most recent action (July 8, 2026): Approved P.L.2026, c.40.
  • 3 recorded votes; the most recent, on June 30, 2026, passed 38-2.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Katz, Andrea, Sweeney, Marisa, Kearney, Vincent M., Tully, Chris, Vitale, Joseph F., Gopal, Vin, Mukherji, Raj

Cosponsors (2): Karabinchak, Robert J., Donlon, Margie, M.D.

History

  1. Introduced, completed
  2. Passed General Assembly, completed
  3. Passed Senate, completed
  4. Sent to Governor, completed
  5. Signed into law, completed, current stage
  1. General Assembly Introduced, Referred to Assembly Health Committee Milestone
  2. General Assembly Transferred to Assembly State and Local Government Committee
  3. General Assembly Reported from Assembly Comm. as a Substitute, 2nd Reading

    Reported out of Assembly committee as a substitute: 7 yes 0 no Passed, 100% yes

  4. General Assembly Passed by the Assembly (76-2-1) Milestone

    3RDG FINAL PASSAGE: 76 yes 2 no, 2 other Passed, 97% yes

  5. Senate Received in the Senate without Reference, 2nd Reading
  6. General Assembly Substituted for S4194/4210 (SCS)
  7. Senate Passed Senate (Passed Both Houses) (38-2) Milestone

    3RDG FINAL PASSAGE: 38 yes 2 no Passed, 95% yes

  8. General Assembly Approved P.L.2026, c.40. Milestone Latest

Source: Open States. Last checked November 10, 2026. How we keep this accurate ›